MicroRNA-146a suppresses tumor malignancy via targeting vimentin in esophageal squamous cell carcinoma cells with lower fibronectin membrane assembly

Table 3 Characteristics of Group I and Group II of ESCC clinical specimens

Characteristics	Group I (ESCC patient specimens)	Group II (non-tumor vs. tumor)
Patients no	68	68
Age (years)
Median age	57	57
Range	36–87	34–82
Sex
Male/female	64/4	65/3
Tumor stages
I	8	6
II	19	14
III	31	43
IV	10	5
Two-year survival
≥ 24 months	32	18
< 24 months	36	50

Group I is the characteristics of ESCC patients for measuring the miR-146a RNA expression levels by real-time RT-PCR
Group II is the characteristics of ESCC patient specimens (non-tumor vs. tumor) for direct detection of miR-146a and vimentin expression levels by ISH and IHC staining

ISSN: 1423-0127